Asymchem Laboratories Tianjin Co (SZSE:002821) Total Liabilities : ¥2,234 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Total Liabilities?

Asymchem Laboratories Tianjin Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥2,234 Mil.

Asymchem Laboratories Tianjin Co's quarterly Total Liabilities declined from Sep. 2023 (¥2,292.38 Mil) to Dec. 2023 (¥2,257.18 Mil) and declined from Dec. 2023 (¥2,257.18 Mil) to Mar. 2024 (¥2,234.47 Mil).

Asymchem Laboratories Tianjin Co's annual Total Liabilities declined from Dec. 2021 (¥2,546.29 Mil) to Dec. 2022 (¥2,544.27 Mil) and declined from Dec. 2022 (¥2,544.27 Mil) to Dec. 2023 (¥2,257.18 Mil).

Asymchem Laboratories Tianjin Co Total Liabilities Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Total Liabilities Chart

Asymchem Laboratories Tianjin Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

713.23

1,191.82

2,546.29

2,544.27

2,257.18

Asymchem Laboratories Tianjin Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															2,176.79	2,404.93	2,292.38	2,257.18	2,234.47

Asymchem Laboratories Tianjin Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Asymchem Laboratories Tianjin Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1800.803	+	(106.486	+	349.891
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,257

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	19767.159	-	17509.979
	=	2,257

Asymchem Laboratories Tianjin Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1768.241	+	(100.9	+	365.324
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,234

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	19841.423	-	17606.959
	=	2,234

Asymchem Laboratories Tianjin Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Asymchem Laboratories Tianjin Co (SZSE:002821) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

06821:Hong Kong 7K90:Germany

Address

No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457

Website

https://www.asymchem.com

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development Manufacture Organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of global pharmaceutical technology.

Executives

Xiao Yi	Executives
Xu Xiang Ke	Directors, executives
Zhou Yan	Executives
Chen Chao Yong	Executives
Huang Xiao Lian	Executives
Yang Jing	Director
	Executives

Asymchem Laboratories Tianjin Co (SZSE:002821) Headlines

No Headlines